Description:
AT-7519 is an orally bioavailable small molecule CDK inhibitor with potential antineoplastic activity. AT7519M selectively binds to and inhibits cyclin dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation.
- Molecular Weight: 418.71
- Molecular Formula: C16H18Cl3N5O2
Canonical SMILES:
C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl.Cl
InChI:
InChI=1S/C16H17Cl2N5O2.ClH/c17-10-2-1-3-11(18)13(10)15(24)22-12-8-20-23-14(12)16(25)21-9-4-6-19-7-5-9;/h1-3,8-9,19H,4-7H2,(H,20,23)(H,21,25)(H,22,24);1H
InChIKey: PAOFPNGYBWGKCO-UHFFFAOYSA-NSynonyms:
AT7519 HCl; AT 7519 HCl; AT-7519 HCl
More details are to be found on supplier website
